Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Natus Medical Inc
(NQ:
NTUS
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jul 20, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Natus Medical Inc
Route 92 Medical Announces Appointment of Jonathan Kennedy as Chief Financial Officer
September 18, 2023
From
Route 92 Medical, Inc.
Via
GlobeNewswire
Novanta Shares Pop On Inclusion Into S&P MidCap 400
July 22, 2022
Via
Benzinga
NATUS MEDICAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Natus Medical Incorporated - NTUS
May 17, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
NATUS MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Natus Medical Incorporated - NTUS
May 05, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
Stocks That Hit 52-Week Highs On Thursday
April 15, 2021
Thursday morning saw 166 companies set new 52-week highs. Interesting Highlights: The largest company by market cap to hit a new 52-week high was Microsoft (NASDAQ:...
Via
Benzinga
68 Biggest Movers From Yesterday
April 19, 2022
Gainers Casa Systems, Inc. (NASDAQ: CASA) shares surged 82.5% to close at $7.10 on Monday after the company announced a multi-year contract with Verizon to provide 5G core...
Via
Benzinga
Mid-Afternoon Market Update: Crude Oil Rises Over 1%; Nektar Therapeutics Shares Slide
April 18, 2022
U.S. stocks traded higher in volatile session, with the Dow Jones gaining around 60 points toward the end of trading on Monday.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
April 18, 2022
Gainers Natus Medical (NASDAQ:NTUS) shares rose 28.8% to $33.55 during Monday's regular session. The current volume of 3.0 million shares is 2073.2% of Natus Medical...
Via
Benzinga
Dow Moves Lower As Wall Street Gears Up For Earnings
April 18, 2022
Stocks are struggling for direction midday, with investor sentiment dampening after the 10-year Treasury yield hit a more than three-year high this morning.
Via
Talk Markets
Mid-Day Market Update: U.S. Stocks Turn Lower; Bank of America Earnings Top Views
April 18, 2022
U.S. stocks turned lower midway through trading, with the Nasdaq Composite falling more than 100 points on Monday.
Via
Benzinga
34 Stocks Moving In Monday's Mid-Day Session
April 18, 2022
Gainers Casa Systems, Inc. (NASDAQ: CASA) shares climbed 66.3% to $6.47 after the company announced a multi-year contract with Verizon to provide 5G core network functions....
Via
Benzinga
Mid-Morning Market Update: Markets Open Higher; Dow Gains 100 Points
April 18, 2022
U.S. stocks traded higher this morning, with the Dow Jones adding around 100 points on Monday.
Via
Benzinga
NTUS Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Natus Medical Incorporated Is Fair to Shareholders
April 18, 2022
From
Halper Sadeh LLP
Via
Business Wire
Benzinga's Daily Brief On Trending Tickers For April 18, 2022: Casa Systems, Twitter, DiDi Global, And More
April 18, 2022
Benzinga’s “Daily Brief On Trending Tickers” features top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 18, 2022
Gainers Natus Medical (NASDAQ:NTUS) stock rose 28.3% to $33.42 during Monday's pre-market session. The market value of their outstanding shares is at $1.1 billion....
Via
Benzinga
Neurodiagnostic Focused Natus Medical Goes Private In $1.2B Deal
April 18, 2022
Natus Medical Inc (NASDAQ: NTUS) will be acquired by ArchiMed, an investment firm focused exclusively on the healthcare industry, for approximately $1.2 billion.
Via
Benzinga
Natus Medical: Q4 Earnings Insights
February 24, 2022
Natus Medical (NASDAQ:NTUS) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
February 07, 2022
On Monday, 71 stocks hit new 52-week lows. Noteable 52-Week Lows: 3M (NYSE:MMM) was the biggest company in terms of market cap to set a new 52-week low. OceanPal (...
Via
Benzinga
The Daily Biotech Pulse: Illunina Announces Multiple Partnerships, Immunome Slides On Regulatory Setback For COVID Antibody Drug, Preannouncements Pour In
January 11, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus BioAtla, Bristol-Myers Squibb Announce Collaboration To Evaluate ADC-Opdivo...
Via
Benzinga
Natus Medical Inc (NTUS) Q3 2021 Earnings Call Transcript
November 05, 2021
NTUS earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Return on Capital Employed Overview: Natus Medical
August 20, 2021
After pulling data from Benzinga Pro it seems like during Q2, Natus Medical (NASDAQ:NTUS) earned $6.01 million, a 33.05% increase from the preceding quarter. Natus Medical also...
Via
Benzinga
Natus Medical Inc (NTUS) Q2 2021 Earnings Call Transcript
August 06, 2021
NTUS earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs
June 18, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 17) 10x Genomics, Inc. (NASDAQ...
Via
Benzinga
Exposures
Product Safety
Stocks That Hit 52-Week Highs On Thursday
June 17, 2021
This morning 94 companies set new 52-week highs. Things to Consider: NVIDIA (NASDAQ:NVDA) was the largest firm by market cap to set a new 52-week high. Deswell Industries...
Via
Benzinga
The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme
June 17, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 16) Alexion Pharmaceuticals,...
Via
Benzinga
Exposures
COVID-19
Top 10 Reddit Stocks As Frenzy Hints At Life Beyond WallStreetBets
June 10, 2021
Reddit stocks were mostly lower while the frenzy behind the rally in the likes of AMC and GameStop shows signs of extending beyond social-media buzz.
Via
Investor's Business Daily
Natus Medical Incorporated (NTUS) Q1 2021 Earnings Call Transcript
May 07, 2021
NTUS earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout
April 27, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 26) 10x Genomics, Inc. (NASDAQ...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
The Daily Biotech Pulse: Precision Biosciences Regains Rights To CAR T Candidates, CFO Changes, 2 IPOs
April 16, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15) Ardelyx, Inc. (NASDAQ:...
Via
Benzinga
The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split
April 15, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 14) 10x Genomics, Inc. (NASDAQ...
Via
Benzinga
Exposures
COVID-19
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.